NI

Nextech Invest Portfolio holdings

AUM $1.03B
1-Year Est. Return 110.77%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+110.77%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.03B
AUM Growth
+$377M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
17
New
Increased
Reduced
Closed

Top Buys

1
+$17M
2
+$14.9M
3
+$6.1M
4
GLUE icon
Monte Rosa Therapeutics
GLUE
+$3.76M

Top Sells

1
+$9.49M
2
+$4.19M
3
+$1.51M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$31B
$605M 58.53%
7,601,087
TYRA icon
2
Tyra Biosciences
TYRA
$1.92B
$107M 10.31%
4,055,861
TNGX icon
3
Tango Therapeutics
TNGX
$3.8B
$64.4M 6.22%
7,266,081
+1,732,101
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.2B
$58.6M 5.66%
7,162,637
RLAY icon
5
Relay Therapeutics
RLAY
$3B
$39.8M 3.85%
4,701,506
+855,097
ZYME icon
6
Zymeworks
ZYME
$2.07B
$29.3M 2.84%
1,113,946
ALMS
7
Alumis Inc
ALMS
$3.18B
$28.5M 2.75%
2,915,998
KYMR icon
8
Kymera Therapeutics
KYMR
$7.16B
$21.7M 2.1%
278,896
-62,013
ENGN icon
9
enGene Therapeutics Inc. Common Stock
ENGN
$541M
$19.2M 1.86%
+2,124,943
MRSN
10
DELISTED
Mersana Therapeutics
MRSN
$14M 1.35%
482,689
CGEM icon
11
Cullinan Oncology
CGEM
$912M
$11.8M 1.14%
1,141,145
CNTX icon
12
Context Therapeutics
CNTX
$223M
$10.9M 1.05%
7,419,355
SPRY icon
13
ARS Pharmaceuticals
SPRY
$812M
$7.7M 0.74%
660,703
ARVN icon
14
Arvinas
ARVN
$704M
$6.4M 0.62%
539,394
-869,000
SLN
15
Silence Therapeutics
SLN
$356M
$5.79M 0.56%
952,400
GLUE icon
16
Monte Rosa Therapeutics
GLUE
$1.58B
$4.38M 0.42%
+279,237
BOLD
17
Boundless Bio
BOLD
$35.4M
– –
-1,228,069